SEC Comment Letter 0000000000-24-005153 to BiomX Inc. (PHGE)
BiomX Inc.
Date: May 6, 2024 · CIK: 0001739174 · Accession: 0000000000-24-005153
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278986
Letter
United States securities and exchange commission logo May 6, 2024 Jonathan Solomon Chief Executive Officer BiomX Inc. 22 Einstein St., Floor 4 Ness Ziona, Israel 7414003 Re:BiomX Inc. Registration Statement on Form S-3 Filed April 29, 2024 File No. 333-278986 Dear Jonathan Solomon: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alla Digilova, Esq.
Show Raw Text
United States securities and exchange commission logo
May 6, 2024
Jonathan Solomon
Chief Executive Officer
BiomX Inc.
22 Einstein St., Floor 4
Ness Ziona, Israel 7414003
Re:BiomX Inc.
Registration Statement on Form S-3
Filed April 29, 2024
File No. 333-278986
Dear Jonathan Solomon:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Alla Digilova, Esq.